In the vibrant coastal city of Durban, South Africa, the curtains fell on the 4th International Conference on Public Health in Africa (CPHIA 2025) on October 25, drawing over 5,000 in-person attendees and tens of thousands virtually from across the globe. Hosted by the Africa Centres for Disease Control and Prevention (Africa CDC) in partnership with the South African government, the four-day event pulsed with urgency and optimism under the theme “Moving towards self-reliance to achieve universal health coverage and health security in Africa.” As delegates departed the Durban International Convention Centre, they carried not just insights but actionable commitments to reshape the continent’s health landscape amid escalating global threats like pandemics, climate crises, and inequities in access to life-saving interventions.
A Grand Opening Sets the Tone for African-Led Solutions
The conference kicked off on October 22 with a resounding opening ceremony, featuring high-level speeches from African Union representatives, South African Health Minister Dr. Zweli Mkhize, and Africa CDC Director General Dr. Jean Kaseya. Minister Mkhize emphasised South Africa’s pivotal role in continental health advancements, highlighting the nation’s strides in HIV management and vaccine manufacturing as beacons for self-reliance. “Africa is no longer a guest at the global health table; we are co-architects,” declared a key organiser, underscoring the shift from dependency to leadership.
Day one delved into tracks like building health security through local manufacturing and innovative financing for universal health coverage (UHC). Sessions buzzed with discussions on pooled procurement mechanisms to bolster vaccine supply chains—a critical response to past inequities exposed by COVID-19. South Africa’s showcase of its science-led health systems drew applause, with experts praising its vaccine-manufacturing facility as a model for scalable, equitable production.
HIV Spotlight: Pledges for Accelerated Equity and Innovation
HIV remained a cornerstone of CPHIA 2025, reflecting Africa’s ongoing battle against a disease that still claims over 630,000 lives annually on the continent. Local sessions in Durban zeroed in on integrating HIV services into primary care frameworks, with South Africa sharing data on its ambitious 95-95-95 targets—aiming for 95% of people living with HIV knowing their status, 95% on treatment, and 95% virally suppressed by 2030.
A pivotal side event, “African Leadership in HIV Vaccine R&D Amid Shifting Global Priorities,” mapped out African-led assets and gaps in vaccine development, especially as international funding wanes. Delegates pledged renewed commitments to the African HIV Vaccine and Therapeutics Initiative, calling for a US $100 million seed fund to fast-track trials for next-generation prophylactics. Local researchers presented promising Phase II data from broadly neutralising antibodies (bNAbs), positioning the nation as a hub for HIV innovation.
“We’ve reduced new infections by 50% in the last decade through community-led testing and treatment,” noted Dr. Yogan Pillay, Deputy Director-General for HIV and AIDS at South Africa’s Department of Health, during a plenary. These wins, he argued, parallel global efforts but demand tailored African strategies to sustain momentum. The session culminated in a collective pledge by 15 African nations to harmonise HIV data platforms, ensuring equitable resource allocation and closing gaps among key populations such as youth and migrants.
Vaccine Equity Takes Centre Stage: From Pledges to Pipelines
Vaccine equity emerged as the conference’s rallying cry, with dedicated tracks addressing manufacturing self-reliance and equitable access. A prominent side event championed strategies for health security, urging a 30% increase in African vaccine production by 2030 to pre-empt future outbreaks. South Africa’s Biovac Institute spotlighted its HPV vaccine rollout, which has vaccinated over 80% of eligible girls—slashing cervical cancer risks and exemplifying scalable equity models.
Panelists from Egypt and Zambia highlighted progress in local production, advocating for BRICS-backed transfers of technology to diversify supply chains. A landmark pledge emerged from the vaccine-financing forum: a US $500 million Africa CDC-led fund for pooled procurement, targeting underserved regions and integrating climate-resilient logistics. “Equity isn’t charity; it’s a strategic imperative,” stressed a major global fund CEO in a virtual address, echoing calls for patent waivers on essential vaccines.
These commitments build on CPHIA’s legacy, where past gatherings catalysed over US $2 billion in health investments. Durban’s sessions reinforced that vaccine sovereignty—producing 60% of Africa’s needs locally by 2040—is non-negotiable for achieving UHC.
Global Echoes: Collaboration and Innovation Across Regions
For international audiences, CPHIA 2025’s emphasis on collaborative surveillance mirrors longstanding health-partnerships globally. Joint programmes have trained over 20,000 health workers, and Durban sessions unveiled an Africa-wide digital dashboard for real-time HIV tracking—an evolution of earlier field-epidemiology models. Kenya’s review noted that external tech infusions have bolstered South Africa’s genomic sequencing for HIV variants.
From an Asian-Pacific perspective, innovation-sharing at CPHIA underscored new horizons in global health equity. As South Africa assumes the 2025 BRICS chair, sessions on “New Horizons in Disease Responses” featured biotech-platform exchanges and a joint BRICS-Africa taskforce on antimicrobial resistance, promising US $200 million in R&D collaborations to tackle super-bugs affecting health systems.
Beyond Borders: Youth, Climate, and Digital Frontiers
Diversifying the narrative, CPHIA 2025 amplified voices from women and youth in Track 6, with sessions like “YES to Health: Why Youth Belong at the Centre” featuring young innovators driving digital health. Over 1,000 young delegates pledged to lead digital innovations—from AI-driven outbreak predictions to tele-medicine platforms for rural HIV care.
Climate change loomed large in Track 5, where Africa CDC launched a landmark Climate & Health Report, projecting 250,000 additional deaths annually by 2030 without integrated One-Health approaches. South Africa’s drought-resilient vaccine-storage pilots were hailed as scalable solutions, blending environmental resilience with health-security.
Digital transformation rounded out the agenda, with Track 4 exploring AI for equitable diagnostics. A prominent global NGO’s booth showcased solar-powered cold-chains, bridging urban-rural divides in vaccine delivery and marking a shift from talk to deployable tech.
A Resonant Close: Charting Africa’s Health Horizon
The closing ceremony on October 25 was a triumphant affair, blending awards for young investigators—honouring breakthroughs in HIV bNAbs and cholera vaccines—with a forward-looking agenda from Africa CDC. The “Durban Declaration,” the conference’s outcome statement, crystallised pledges: US $1.2 billion mobilised for manufacturing hubs, harmonised HIV policies across 20 nations, and a BRICS-aligned innovation accelerator.
As confetti settled, Dr. Jean Kaseya reflected, “CPHIA 2025 isn’t an endpoint; it’s a launchpad.” South Africa’s triumphs—from slashing HIV mother-to-child transmission to pioneering vaccine tech—stand as proof that amid global challenges, African ingenuity prevails. The real work begins now: translating Durban’s momentum into resilient systems that safeguard every life, from Cape to Cairo.
With echoes of collaboration resonating worldwide, CPHIA 2025 reaffirms Africa’s ascent in global health. Stakeholders around the globe see in these wins a blueprint for equitable futures—proving that self-reliance isn’t isolation—it’s empowerment.